Biomarker discovery in hepatocellular carcinoma (HCC) for personalized treatment and enhanced prognosis

Yu, Baofa; Ma, Wenxue

doi:10.1016/j.cytogfr.2024.08.006

Cytokine & Growth Factor Reviews

2024

DOI: 10.1016/j.cytogfr.2024.08.006

|View full text |Cite

Biomarker discovery in hepatocellular carcinoma (HCC) for personalized treatment and enhanced prognosis

Baofa Yu,

Wenxue Ma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 130 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Liquid biopsy: Comprehensive overview of circulating tumor DNA (Review)

Ge,

Zhang,

et al. 2024

Oncol Lett

View full text Add to dashboard Cite

Traditional tumor diagnosis methods rely on tissue biopsy, which can be invasive and unsuitable for long-term monitoring of tumor dynamics. The advent of liquid biopsy has notably improved the overall management of patients with cancer. Liquid biopsy techniques primarily involve detection of circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA). The present review focuses on ctDNA because of its significance in tumor diagnosis, monitoring and treatment. The use of ctDNA-based liquid biopsy offers several advantages, including non-invasive or minimally invasive collection methods, the ability to conduct repeated assessment and comprehensive insights into tumor biology. It serves crucial roles in disease management by facilitating screening of high-risk patients, dynamically monitoring therapeutic responses and diagnosis. Furthermore, ctDNA can be used to demonstrate pseudo-progression, monitor postoperative tumor status and guide adaptive treatment plans. The present study provides a comprehensive review of ctDNA, exploring its origins, metabolism, detection methods, clinical role and the current challenges associated with its application.

show abstract

Liquid biopsy: Comprehensive overview of circulating tumor DNA (Review)

Ge,

Zhang,

et al. 2024

Oncol Lett

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Biomarker discovery in hepatocellular carcinoma (HCC) for personalized treatment and enhanced prognosis

Cited by 1 publication

References 130 publications

Liquid biopsy: Comprehensive overview of circulating tumor DNA (Review)

Liquid biopsy: Comprehensive overview of circulating tumor DNA (Review)

Contact Info

Product

Resources

About